跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BISOLTUSGRIP JUNIOR POLVO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BISOLTUSGRIP JUNIOR POLVO PARA SOLUCION ORAL
Approved
STANDARD
BISOLTUSGRIP JUNIOR POLVO PARA SOLUCION ORAL
Opella Healthcare Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2022
Approval ID
d20a747e93f5403e
Company
Opella Healthcare Spain S.L.
Type
Standard
Approval Details
Approval Id
d20a747e93f5403e
Drug Cima Aemps Name
BISOLTUSGRIP JUNIOR POLVO PARA SOLUCION ORAL
Register Number
87917
Holder Company Name
Opella Healthcare Spain S.L.
Marketing Company Name
Opella Healthcare Spain S.L.
Authorization Date
2022-07-01
Dosage Form
POLVO PARA SOLUCIÓN ORAL
Dose
300 mg /2 mg/15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Opella Healthcare Spain S.L.
Active Ingredients
PARACETAMOL
300 mg
DEXTROMETORFANO HIDROBROMURO
15 mg
CLORFENAMINA MALEATO
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2022
Approval ID
d20a747e93f5403e
Type
Standard
Back to CIMA-AEMPS Approvals
